{
    "type": "ETF",
    "ucits": true,
    "replication_method": "physical",
    "leverage": false,
    "derivatives": false,
    "swaps": false,
    "inverse": false,
    "complex_factors": [
        "Complex ESG screening methodology",
        "Emerging market exposure",
        "Potential for limited derivative usage (though not for core strategy)"
    ],
    "classification": "non-complex",
    "supporting_data": "The iShares MSCI EM SRI UCITS ETF is classified as non-complex under MiFID II for the following reasons:1. **Physical Replication**: The fund uses physical replication as its primary method (confirmed in the factsheet: 'Methodology: Replicated'). While derivatives may be used for limited purposes (e.g., efficient portfolio management), they are not a core part of the strategy.2. **No Leverage or Inverse Exposure**: The fund does not employ leverage or inverse strategies, and its beta is 1.00 (neutral exposure).3. **Transparent Underlying Assets**: The fund invests in 224 liquid emerging market equities, with no exposure to complex instruments like CoCos, AT1 bonds, or CLOs.4. **ESG Complexity Not a MiFID II Factor**: While the ESG screening methodology is sophisticated, MiFID II complexity is not triggered by ESG criteria alone unless they obscure the fund's risk profile (which is not the case here).5. **No Counterparty Risk from Swaps**: The fund does not use swaps for replication (unlike synthetic ETFs), and any derivative usage is incidental (e.g., hedging).6. **Risk Profile Alignment**: The risk rating (6/7) is consistent with emerging market equities, and risks are clearly disclosed (currency, liquidity, ESG screening).**Counterargument Consideration**: Some might argue that the ESG screening adds complexity, but MiFID II focuses on financial structure rather than thematic complexity. The fund's risks are well-documented and align with its equity exposure.**Confidence Score**: 90% (high confidence due to physical replication, no leverage, and transparent holdings).",
    "confidence": 90
}